Poll result: “our” lumbar puncture trial has a name!

P
“The oxcarbazepine trial in SPMS has a name. Thank you.”

PROXIMUS PRotective role of OXcarbazepine In MUltiple Sclerosis



“The results are quite interesting; not  only did PROXIMUS get the most votes it also had the best profile on the Lickert scale with majority voting for 4 or 5, i.e. excellent.”

Other posts of interest in relation to the PROXIMUS trial:

07 Feb 2012
This study reports the preliminary findings about your views on the potential of having repeated lumbar punctures as part of a novel trial design. Prof G made a video for watching before taking the survey. This indicated that 
05 Jul 2012
A big hurdle to overcome to do this trial is whether or not MS’ers are prepared to have lumbar punctures as part of a clinical trial. To assess this we have prepared a short education video describing the trial design and how we 
25 May 2011
Why repeated lumbar punctures to assess neuroprotective trials? In response to one of the comments from my posting in relation to disease outcomes. In MS damage to nerve processes called axons releases proteins into the 
24 Oct 2012
As you know Team G and UCL partners have been awarded funds to do a trial on performing serial lumbar punctures (spinal taps) to monitor the effect of a neuroprotective drug (oxcarbazipine) currently used in epilepsy on 
09 Aug 2012
Without your help we never have got it funded; you provide the necessary data to convince the reviewers’ that MSers are prepared to have multiple lumbar punctures as part of a clinical trial. This study will involve a 

About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.

5 comments

By Prof G

Translate

Categories

Recent Posts

Recent Comments

Archives